Skip to main content
padlock icon - secure page this page is secure

Oral treatment with yolk antibodies for the prevention of C. albicans infections in chemotherapy treated children. A feasibility study

Buy Article:

$61.00 + tax (Refund Policy)

Cancer patients treated with chemotherapy often become neutropenic, which predisposes for oral and systemic C. albicans infections. The purpose of this feasibility study was to find out if gargling with anti- C. albicans immunoglobulin Y from egg yolk can prevent oral candidiasis in children, treated for acute lymphatic leukemia. Four patients gargled with the antibodies once a day during the induction phase of chemotherapy. None of four patients treated with IgY got any C. albicans infection. In the non-treated control and in a historic group, seven of thirteen patients had suspected C. albicans infection. This study indicates that anti- C. albicans IgY may prevent oral candidiasis in immunocompromized children.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: C. albicans; Oral immunotherapy; acute lymphatic leukemia; children; yolk antibodies

Document Type: Research Article

Affiliations: 1: Department of Pediatrics, Clinical Chemistry, University Hospital, Uppsala, Sweden 2: Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, Sweden

Publication date: March 1, 2005

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more